v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
SCHEDULE OF OUTSTANDING WARRANTS AND CHANGES

A summary of the status of the Company’s total outstanding warrants and changes during the three months ended March 31, 2026 and 2025 are as follows:

 

  

Number of

Warrants

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term (Years)

  

Aggregate

Intrinsic

Value (1)

 
Balance Outstanding on December 31, 2025   2,135,688   $5.88    2.6   $114,424 
Issued   -    -    -    - 
Balance Outstanding on March 31, 2026   2,135,688   $5.88    2.4   $88,033 
Exercisable, March 31, 2026   2,135,688   $5.88    2.4   $88,033 

 

(1) The aggregate intrinsic value on March 31, 2026 and December 31, 2025 was calculated based on the Nasdaq’s market close on March 31, 2026 December 31, 2025, respectively and the exercise price of the underlying the warrants.

 

  

Number of

Warrants

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term (Years)

  

Aggregate

Intrinsic

Value (1)

 
Balance Outstanding on December 31, 2024   125,531   $4.09    3.3   $90,952 
Issued   12,500    4.07    5.0    - 
Balance Outstanding on March 31, 2025   138,031   $4.09    3.2   $23,599 
Exercisable, March 31, 2025   125,531    4.09    3.0   $23,599 

 

(1) The aggregate intrinsic value on March 31, 2025 and December 31, 2024 was calculated based on the Nasdaq’s market close on March 31, 2025 December 31, 2024, respectively and the exercise price of the underlying the warrants.
SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODEL TO WARRANTS GRANTED ASSUMPTION

The Company did not grant any warrants during the three months ended March 31, 2026. The warrants granted during the three months ended March 31, 2025 were valued using the Black-Scholes option pricing model using the following weighted average assumptions:

 

   March 31,   March 31, 
   2026   2025 
Expected term, in years   -    5.0 
Expected volatility   -    54.41%
Risk-free interest rate   -    4.01%
Dividend yield   -    0.00%
SCHEDULE OF STOCK OPTION ACTIVITY

A summary of the Company’s stock option activity during the three months ended March 31, 2026 and 2025 is as follows:

 

   Shares Underlying Options   Weighted Average Exercise Price   Weighted Average Contractual Life (Years)  

Intrinsic

Value

 
Outstanding at December 31, 2025   2,265,427   $4.86    4.66   $528,725 
Granted   225,000    4.52    4.98    - 
Forfeited   -    -    -    - 
Exercised   -    -    -    - 
Outstanding at March 31, 2026   2,490,427   $4.83    4.46   $303,325 
                     
Exercisable at March 31, 2026   1,565,427   $4.34    4.38   $129,325 

 

   Shares Underlying Options   Weighted Average Exercise Price   Weighted Average Contractual Life (Years)  

Intrinsic

Value

 
Outstanding at December 31, 2024   322,500   $3.40    4.97   $138,675 
Granted   350,000    7.36    5.00    - 
Forfeited   -    -    -    - 
Exercised   -    -    -    - 
Outstanding at March 31, 2025   672,500   $5.46    2.56   $- 
                     
Exercisable at March 31, 2025   236,250   $3.91    4.78   $- 
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS OF OPTIONS

The options granted during the three months ended March 31, 2026 and 2025 were valued using the Black-Scholes option pricing model using the following weighted average assumptions:

 

   March 31, 2026  

March 31, 2025

 
Expected term, in years   3.22    5.0 
Expected volatility   43.86%   55.79%
Risk-free interest rate   3.86%   4.09%
Dividend yield   -    -